Placebo + ABT-719
Phase 2Terminated 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Cardiothoracic Surgery
Conditions
Cardiothoracic Surgery, Vascular Surgery
Trial Timeline
May 1, 2013 → May 1, 2014
NCT ID
NCT01897519About Placebo + ABT-719
Placebo + ABT-719 is a phase 2 stage product being developed by AbbVie for Cardiothoracic Surgery. The current trial status is terminated. This product is registered under clinical trial identifier NCT01897519. Target conditions include Cardiothoracic Surgery, Vascular Surgery.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01897519 | Phase 2 | Terminated |